Based on the European Society of Endocrinology/Endocrine Society joint clinical guideline, which of the statements about glucocorticoid tapering are correct?

Neoadjuvant endocrine therapy studies for breast cancer are a great opportunity to develop insights into the biologic basis for the efficacy of estrogen receptor–targeting agents. Neoadjuvant ...

Younger women with endocrine-sensitive (ie, estrogen receptor [ER]-positive or progesterone receptor [PR]-positive and human epidermal growth factor receptor 2-negative) breast cancer benefit from ...

MammaPrint was the only test to predict significant 36% and 52% reductions in DFS and BCFI events, respectively, for patients treated with extended endocrine therapy MammaPrint testing for endocrine ...